Correction: Long pentraxin 3 (PTX3) regulates IL-17A-mediated secondary immunity to Leishmania major infection in mice

Read full text Summarise with VIRAT
Authors: Gaurav Gupta, Zhirong Mou, Ping Jia, Chukwunonso Onyilagha, Lianyu Shan, Abdelilah Soussi-Gounni, Jude Ezeh Uzonna
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Adding/removing text [ "In the published article, there was a mistake as we have missed including a sentence in the Introduction section (changes in the 2nd and 3rd paragraph in the introduction section) of the manuscript without which the sentence looks incomplete and inconclusive." ]. A correction has been made to the section [Section: INTRODUCTION,Paragraph Number 2& 3]: "[PTX3 is an acute phase inflammatory protein, comprising of a signal peptide, an N-terminal domain unrelated to any known protein, and a C-terminal pentraxin domain homologous to the short pentraxins, CRP and SAP (6, 7). Expressed by immune and non-immune cells (8), it has a dual role in infection. While protective against bacterial, viral, and fungal pathogens, PTX3 has also been implicated in disease susceptibility (9, 10). We recently showed that PTX3 is induced during L. major infection and suppresses Th17 responses without affecting Th1 immunity (11). Thus, PTX3-deficient (PTX3 -/-) mice show enhanced resistance to primary L. major infection compared to wild-type controls (11). Although this suppression hinders primary immunity, its role in regulating secondary immunity remains unclear. Furthermore, if this enhanced primary immunity does not translate to robust secondary immunity, targeting PTX3 may not be a viable therapeutic approach for individuals in endemic regions who face repeated exposures to Leishmania.]"The original version of this article has been updated.

Fields of Study & Subjects

Biomarkers in Disease Mechanisms Research on Leishmaniasis Studies Leprosy Research and Treatment

Publication details

Journal / source
Frontiers in Immunology
Volume
17
Pages
1817792–1817792
Publication date
18 March 2026
Language
EN